Literature DB >> 28577595

A strategy to identify and quantify closely related adulterant herbal materials by mass spectrometry-based partial least squares regression.

Li Wang1, Li-Fang Liu1, Jian-Ying Wang1, Zi-Qi Shi2, Wen-Qi Chang1, Meng-Lu Chen1, Ying-Hao Yin1, Yan Jiang3, Hui-Jun Li1, Ping Li1, Zhong-Ping Yao4, Gui-Zhong Xin5.   

Abstract

In this study, a new strategy combining mass spectrometric (MS) techniques with partial least squares regression (PLSR) was proposed to identify and quantify closely related adulterant herbal materials. This strategy involved preparation of adulterated samples, data acquisition and establishment of PLSR model. The approach was accurate, sensitive, durable and universal, and validation of the model was done by detecting the presence of Fritillaria Ussuriensis Bulbus in the adulteration of the bulbs of Fritillaria unibracteata. Herein, three different MS techniques, namely wooden-tip electrospray ionization mass spectrometry (wooden-tip ESI/MS), ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS) and UPLC-triple quadrupole tandem mass spectrometry (UPLC-TQ/MS), were applied to obtain MS profiles for establishing PLSR models. All three models afforded good linearity and good accuracy of prediction, with correlation coefficient of prediction (rp2) of 0.9072, 0.9922 and 0.9904, respectively, and root mean square error of prediction (RMSEP) of 0.1004, 0.0290 and 0.0323, respectively. Thus, this strategy is very promising in tracking the supply chain of herb-based pharmaceutical industry, especially for identifying adulteration of medicinal materials from their closely related herbal species.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fritillariae cirrhosae bulbus; Herbal adulteration; Mass spectrometric techniques; Partial least squares regression

Mesh:

Substances:

Year:  2017        PMID: 28577595     DOI: 10.1016/j.aca.2017.04.023

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  7 in total

1.  Dose Optimization of Anxiolytic Compounds Group in Valeriana jatamansi Jones and Mechanism Exploration by Integrating Network Pharmacology and Metabolomics Analysis.

Authors:  Chengbowen Zhao; Xiaojia Wei; Jianyou Guo; Yongsheng Ding; Jing Luo; Xue Yang; Jiayuan Li; Guohui Wan; Jiahe Yu; Jinli Shi
Journal:  Brain Sci       Date:  2022-04-30

Review 2.  Natural drug sources for respiratory diseases from Fritillaria: chemical and biological analyses.

Authors:  Ye Wang; Hongping Hou; Qiang Ren; Haoyu Hu; Tiechui Yang; Xiwen Li
Journal:  Chin Med       Date:  2021-05-31       Impact factor: 5.455

Review 3.  Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Authors:  Yunyun Quan; Li Li; Zhujun Yin; Shilong Chen; Jing Yi; Jirui Lang; Lu Zhang; Qianhua Yue; Junning Zhao
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

4.  A metabolomic strategy based on integrating headspace gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry to differentiate the five cultivars of Chrysanthemum flower.

Authors:  Lin-Ning Zhang; Long Wang; Zi-Qi Shi; Ping Li; Hui-Jun Li
Journal:  RSC Adv       Date:  2018-03-01       Impact factor: 4.036

Review 5.  Advances in Fingerprint Analysis for Standardization and Quality Control of Herbal Medicines.

Authors:  Eka Noviana; Gunawan Indrayanto; Abdul Rohman
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

6.  Phytochemical Characterization of Mentha spicata L. Under Differential Dried-Conditions and Associated Nephrotoxicity Screening of Main Compound With Organ-on-a-Chip.

Authors:  Xian Li; Tian Tian
Journal:  Front Pharmacol       Date:  2018-09-28       Impact factor: 5.810

Review 7.  Traditional Asian Herbs in Skin Whitening: The Current Development and Limitations.

Authors:  Yibo Hu; Hongliang Zeng; Jinhua Huang; Ling Jiang; Jing Chen; Qinghai Zeng
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.